AVITA Medical Valuation Multiples

AVITA Medical Overview

About AVITA Medical

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Founded

1992

HQ

Employees

226

Website

avitamedical.com

Sectors

Medical Devices

Financials (LTM)

Revenue: $74M

EBITDA: ($35M)

EV

$153M

Valuation Multiples

Multiples.vc

Start free trial

AVITA Medical Financials

AVITA Medical reported last 12-month revenue of $74M and negative EBITDA of ($35M).

In the same LTM period, AVITA Medical generated $61M in gross profit, ($35M) in EBITDA losses, and had net loss of ($45M).

AVITA Medical P&L

In the most recent fiscal year, AVITA Medical reported revenue of $72M and EBITDA of ($40M).

AVITA Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

AVITA Medical Stock Performance

AVITA Medical has current market cap of $125M, and enterprise value of $153M.

AVITA Medical's stock price is $0.82.

AVITA Medical Valuation Multiples

AVITA Medical trades at 2.1x EV/Revenue multiple, and (4.3x) EV/EBITDA.

AVITA Medical Financial Valuation Multiples

As of April 11, 2026, AVITA Medical has market cap of $125M and EV of $153M.

Equity research analysts estimate AVITA Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

AVITA Medical has a P/E ratio of (2.8x).

AVITA Medical Margins & Growth Rates

AVITA Medical's revenue in the last 12 month grew by 25%.

AVITA Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.4M for the same period.

AVITA Medical's rule of 40 is (13%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AVITA Medical's rule of X is 10% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

AVITA Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

AVITA Medical M&A Activity

AVITA Medical acquired XXX companies to date.

Last acquisition by AVITA Medical was on XXXXXXXX, XXXXX. AVITA Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

AVITA Medical Investment Activity

AVITA Medical invested in XXX companies to date.

AVITA Medical made its latest investment on XXXXXXXX, XXXXX. AVITA Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).